Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravis

Björn Oskarsson, Steven P. Ringel

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Many neuromuscular conditions cause bulbar and limb weakness, and when several conditions coexist they present additional diagnostic challenges. Here we describe a case of a 45-year-old woman with antibody positive myasthenia gravis since age 16, who then develops treatment-resistant weakness due to genetically proven oculopharyngeal muscular dystrophy. We conclude that the development of treatment-resistant weakness in myasthenia gravis should spur further work up for other neuromuscular disorders including oculopharyngeal muscular dystrophy.

Original languageEnglish (US)
Pages (from-to)316-318
Number of pages3
JournalNeuromuscular Disorders
Volume23
Issue number4
DOIs
StatePublished - Apr 2013

Keywords

  • Myasthenia gravis (MG)
  • Oculopharyngeal muscular dystrophy (OPMD)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Clinical Neurology
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravis'. Together they form a unique fingerprint.

  • Cite this